Mild Cognitive Impairment
WHAT IS MILD COGNITIVE IMPAIRMENT?
- Mild Cognitive Impairment (MCI) is a measurable decline in memory or other cognitive abilities that is greater than expected for age, while independence in daily activities is largely preserved. It is considered an intermediate stage between normal cognitive aging and dementia.
WHAT ARE THE TWO TYPES OF MCI?
- Amnestic MCI: primarily affects memory.
- Non-amnestic MCI: primarily affects other cognitive domains such as executive function, language, attention, or visuospatial skills.
Source: Alzheimer’s Association. 2023 Alzheimer’s Disease Facts and Figures
statistics:
- Prevalence (Age ≥65): Approximately 10–20%.
- Global prevalence (Age ≥50): 15.6% (95% CI 13.2–18.0)
- Annual progression to dementia: Approximately 10–15% per year
Sources: National Institute on Aging. What Is Mild Cognitive Impairment? 2023, GBD 2019 MCI Collaborators. Age and Ageing. 2022, Alzheimer’s Association. 2023 Alzheimer’s Disease Facts and Figures.
Living With MCI
While MCI increases dementia risk, many individuals remain stable for years. Evidence-based strategies that may help maintain cognitive function and overall health include:
Regular Physical Activity
Aerobic exercise (for example brisk walking 150 minutes per week) is associated with improved cognitive performance and reduced progression risk.
Cardiovascular Risk Management
Control of hypertension, diabetes, hyperlipidemia, and smoking reduces vascular contributions to cognitive decline.
Cognitive Engagement
Structured cognitive training, learning new skills, reading, and social interaction support cognitive reserve.
Sleep Optimization
Address sleep apnea, insomnia, and poor sleep quality, as sleep disturbances are associated with accelerated cognitive decline.
Nutrition
Mediterranean-style dietary patterns emphasizing fruits, vegetables, whole grains, fish, olive oil, and limited processed foods are associated with better cognitive outcomes.
Routine Monitoring
Regular follow-up with a healthcare professional allows monitoring of change, medication review, and early detection of progression.
Eligibility Criteria
Each clinical study is unique and may have its own age requirements and eligibility criteria. Participation qualifications vary by study protocol.
Mild Cognitive Impairment Study
Male
Age
50+ years
Mild Cognitive Impairment Study
Female
Age
50+ years
Sign Up Form
Thank you for your interest in Participating in one of our clinical studies. See if you may qualify by answering a few short questions. By filling out the interest form below, you consent to being contacted by our patient enrollment specialists via phone, text, or email with more information.